Ebastine Versus Mebeverine in IBS Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 30, 2023

Primary Completion Date

October 1, 2027

Study Completion Date

January 1, 2028

Conditions
IBS - Irritable Bowel SyndromeIBS
Interventions
DRUG

Ebastine

"Randomized subjects will administer 4 pills of study medication per day during 12 weeks.~Daily administration schedule consists of taking 2 pills in the morning (1 verum, and 1 placebo). In the evening, subjects will take a second dose of both verum and placebo."

DRUG

Duspatalin

"Randomized subjects will administer 4 pills of study medication per day during 12 weeks.~Daily administration schedule consists of taking 2 pills in the morning (1 verum, and 1 placebo). In the evening, subjects will take a second dose of both verum and placebo."

Trial Locations (5)

2000

RECRUITING

GZA, Antwerp

RECRUITING

UZA, Antwerp

2800

RECRUITING

AZ St-Maarten, Mechelen

3000

RECRUITING

UZLeuven, Leuven

8310

RECRUITING

AZ St-Lucas, Bruges

All Listed Sponsors
collaborator

Fund for Scientific Research, Flanders, Belgium

OTHER

lead

Guy Boeckxstaens

OTHER